Anti-EGFR monoclonal antibodies enhance sensitivity to DNA-damaging agents in BRCA1 -mutated and PTEN -wild-type triple-negative breast cancer cells - Université Clermont Auvergne
Article Dans Une Revue Molecular Carcinogenesis Année : 2017

Anti-EGFR monoclonal antibodies enhance sensitivity to DNA-damaging agents in BRCA1 -mutated and PTEN -wild-type triple-negative breast cancer cells

Fichier non déposé

Dates et versions

hal-01671367 , version 1 (22-12-2017)

Identifiants

Citer

Abderrahim El Guerrab, Mahchid Bamdad, Yves-Jean Bignon, Frédérique Penault-Llorca, Corinne Aubel. Anti-EGFR monoclonal antibodies enhance sensitivity to DNA-damaging agents in BRCA1 -mutated and PTEN -wild-type triple-negative breast cancer cells. Molecular Carcinogenesis, 2017, 56 (5), pp.1383 - 1394. ⟨10.1002/mc.22596⟩. ⟨hal-01671367⟩
72 Consultations
0 Téléchargements

Altmetric

Partager

More